| Application no. and date | 01202986.4 (espacenet) (Federated) (European Patent Register), 19980409 | | Patent/reg. no. and date | DK/EP 1155696, 20040303 | | Publication date | 20011121 | | Priority no. and date | US 43094, 19970415 | | EP pub. no. and date |
EP 1155696 20011121 | | Effective date | | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, Indiana 46285, US | | Applicant ref. no. | P200101661 EP DK | | Inventor | Bymaster, Franklin Porter, 8545 North 650 East
Brownsburg,
Indiana 46112, US,
Tollefson, Gary Dennis, 9052 Diamond Pointe
Indianapolis,
Indiana 46236, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 25/00, A61K 31/551 | | Title | Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
